Differential effects of statins on plasma and brain cholinesterase activities in chicks


  • Hussein Mohammed Rashid Department of Pharmacology, College of Pharmacy, University of Duhok, Duhok, Kurdistan Region, Iraq
  • Fouad Kasim Mohammad Department of Physiology, Biochemistry and Pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq https://orcid.org/0000-0002-5715-4823




Atorvastatin, Fluvastatin, Simvastatin, Cholinesterase, Dyslipidemia


Statins used to treat dyslipidemia may differentially modulate cholinesterase (ChE) activity impacting neuronal function. This study examines the effects of three statins (atorvastatin, fluvastatin, and simvastatin) on plasma and brain ChE activities and cholesterol levels in a chick model of 7-14 days old. Chicks were dosed orally with single doses of each statin at 50, 100, and 200mg/kg or repeated doses at 100mg/kg/day for 14 consecutive days. Plasma and whole brain ChE activities were measured electrometrically, whereas cholesterol levels were measured using a commercial colourimetric kit. In vitro ChE inhibition by the statins was initiated at 37°C for 10 mins. Data were statistically analysed using analysis of variance followed by the least significant difference test. Atorvastatin and fluvastatin did not significantly affect plasma ChE activities 2 hours after the oral administration, whereas simvastatin at 100 and 200mg/kg significantly increased (28% and 16%, respectively) plasma ChE activity. Repeated oral doses of the statins did not significantly affect plasma ChE activity. However, only simvastatin significantly decreased whole brain ChE activity by 33%. Repeated treatments with the three statins significantly reduced cholesterol levels in the plasma but not in the whole brain. The three statins inhibited in vitro plasma and whole brain ChE activities by 10-33% and 8-43%, respectively. The results suggested that the statins differentially modulated ChE activity in vivo and in vitro in chicks. Additional in vivo studies are warranted on statin effects on ChE activity in different brain regions of animal models.


Bocan T. M. (2002). Pleiotropic effects of HMG-CoA reductase inhibitors. Current opinion in investigational drugs (London, England: 2000), 3(9), 1312–1317.

Butterfield, D. A., Barone, E., & Mancuso, C. (2011). Cholesterol-independent neuroprotective and neurotoxic activities of statins: Perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders. Pharmacological Research, 64(3), 180–186. https://doi.org/10.1016/j.phrs.2011.04.007

Cibickova, L. (2011). Statins and their influence on brain cholesterol. Journal of Clinical Lipidology, 5(5), 373–379. https://doi.org/10.1016/j.jacl.2011.06.007

Cibickova, L., Hyšpler, R., Micuda, S., Cibicek, N., Zivna, H., Jun, D., Ticha, A., Brcakova, E., & Palicka, V. (2009). The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta, and cholesterol synthesis in rat brain. Steroids, 74(1), 13–19. https://doi.org/10.1016/j.steroids.2008.08.007

Cibickova, L., Palicka, V., Cibicek, N., Čermáková, E., Micuda, S., Bartosova, L., & Jun, D. (2007). Differential effects of statins and alendronate on cholinesterases in serum and brain of rats. Physiological Research, 56(6), 765–770. https://doi.org/10.33549/physiolres.931121

Climent, E., Benaiges, D., & Pedro-Botet, J. (2021). Hydrophilic or lipophilic statins? Frontiers in Cardiovascular Medicine, 8, 687585. https://doi.org/10.3389/fcvm.2021.687585

Darvesh, S., Martin, E., Walsh, R., & Rockwood, K. (2004). Differential effects of lipid-lowering agents on human cholinesterases. Clinical Biochemistry, 37(1), 42–49. https://doi.org/10.1016/j.clinbiochem.2003.09.004

Donovan, D. A., & Zinkl, J. G. (1994). Modifications of a cholinesterase method for determination of erythrocyte cholinesterase activity in wild mammals. Journal of wildlife diseases, 30(2), 234–240. https://doi.org/10.7589/0090-3558-30.2.234

Fan, H., Zhou, J., & Yuan, Z. (2021). Meta-analysis comparing the effect of combined omega-3+ statin therapy versus statin therapy alone on coronary artery plaques. American Journal of Cardiology, 151, 15–24. https://doi.org/10.1016/j.amjcard.2021.04.013

Ghodke, R. M., Tour, N. S., & Devi, K. (2012). Effects of statins and cholesterol on memory functions in mice. Metabolic Brain Disease, 27(4), 443–451. https://doi.org/10.1007/s11011-012-9343-5

Hirota, T., Fujita, Y., & Ieiri, I. (2020). An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opinion on Drug Metabolism & Toxicology, 16(9), 809–822. https://doi.org/10.1080/17425255.2020.1801634

Husain, I., Akhtar, M., Abdin, M. Z., Islamuddin, M., Shaharyar, M., & Najmi, A. K. (2018). Rosuvastatin ameliorates cognitive impairment in rats fed with high-salt and cholesterol diet via inhibiting acetylcholinesterase activity and amyloid beta peptide aggregation. Human & Experimental Toxicology, 37(4), 399–411. https://doi.org/10.1177/0960327117705431

Kammon, A. M., Brar, R.S., Banga, H.S. & Sodhi, S. (2010). Patho-biochemical studies on hepatotoxicity and nephrotoxicity on exposure to chlorpyrifos and imidacloprid in layer chickens. Veterinarski arhiv, 80(5), 663–672. https://hrcak.srce.hr/62160

Kandiah, N., & Feldman, H. (2009). Therapeutic potential of statins in Alzheimer’s disease. Journal of the Neurological Sciences, 283(1–2), 230–234. https://doi.org/10.1016/j.jns.2009.02.352

Kelly, L. M., & Alworth, L. C. (2013). Techniques for collecting blood from the domestic chicken. Lab Animal, 42(10), 359–361. https://doi.org/10.1038/laban.394

Macan, M., Vukšić, A., Žunec, S., Konjevoda, P., Lovrić, J., Kelava, M., Štambuk, N., Vrkić, N., & Bradamante, V. (2015). Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidemic rats. Pharmacological Reports, 67(5), 907–913. https://doi.org/10.1016/j.pharep.2015.02.005

McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016). Statins for the prevention of dementia. The Cochrane Library, 2016(1), CD003160. https://doi.org/10.1002/14651858.cd003160.pub3

Mohammad, F. K. (2007). Review of a Practical Electrometric method for determination of Blood and Tissue Cholinesterase activities in Animals. VetScan, 2(2), 1–12. https://journal.vetscan.co.in/index.php/vs/issue/view/5

Mohammad, F. K., Al-Baggou, B. K., Naser, A., & Fadel, M. (2014). In vitro inhibition of plasma and brain cholinesterases of growing chicks by chlorpyrifos and dichlorvos. Journal of Applied Animal Research, 42(4), 423–428. https://doi.org/10.1080/09712119.2013.875912

Mohammad, F. K., Mousa, Y. J., Al-Zubaidy, M. H. I., & Alias, A. S. (2012). Assessment of diphenhydramine effects against acute poisoning induced by the organophosphate insecticide dichlorvos in chicks. Human and Veterinary Medicine, 4(1), 6–13. http://www.hvm.bioflux.com.ro/docs/HVM_4.1.2.pdf

Mohammad, F.K. (2010). Laboratory guide in toxicology, 2nd edition. Mizzou Media, University of Missouri. https://in.b-ok.as/book/16382014/9cfdef

Mohammed, A. A., & Mohammad, F. K. (2022a). Recognition and assessment of antidotal effects of diphenhydramine against acute carbaryl insecticide poisoning in a chick model. Toxicology International, 29(3), 339–352. https://doi.org/10.18311/ti/2022/v29i3/29732

Mohammed, A. A., & Mohammad, F. K. (2022b). Monitoring blood cholinesterase activity of farmworkers: in vitro inhibition by diphenhydramine and carbaryl. Malaysian Applied Biology, 51(2), 23–32. https://doi.org/10.55230/mabjournal.v51i2.2204

Motti, C., Gnasso, A., & Cortese, C. (2000). Statins: similarities and differences in the pharmacological, clinical and laboratory aspects. Annali Italiani di Medicina Interna, 15(1): 96–102.

Mozayan, M., & Lee, T. J. (2007). Statins prevent cholinesterase inhibitor blockade of sympathetic α7-nAChR-mediated currents in rat superior cervical ganglion neurons. American Journal of Physiology-heart and Circulatory Physiology, 293(3), H1737–H1744. https://doi.org/10.1152/ajpheart.00269.2007

Muačević-Katanec, D., Bradamante, V., Reiner, Ž., Sučić, M., Poljičanin, T., Bušljeta, I., & Metelko, Ž. (2005). Clinical study on the effect of simvastatin on butyrylcholinesterase activity. Arzneimittel-Forschung, 55(5), 271–275. https://doi.org/10.1055/s-0031-1296856

Petrie, A., & Watson, P. (2013). Statistics for veterinary and animal science, 3rd Edition. Wiley-Blackwell eBooks. https://www.cabdirect.org/cabdirect/abstract/20073129131

Pytel, E., Bukowska, B., Koter-Michalak, M., Olszewska-Banaszczyk, M., Gorzelak-Pabiś, P., & Broncel, M. (2017). Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease. Pharmacological Reports, 69(1), 150–155. https://doi.org/10.1016/j.pharep.2016.09.016

Roensch, J., Crisby, M., Nordberg, A., Xiao, Y., Zhang, L., & Guan, Z. (2007). Effects of statins on α7 nicotinic receptor, cholinesterase, and α-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochemistry International, 50(6), 800–806. https://doi.org/10.1016/j.neuint.2007.02.001

Sharma, B., Singh, N., & Singh, M. (2008). Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer’s disease by pitavastatin and donepezil. Journal of Psychopharmacology, 22(2), 162–171. https://doi.org/10.1177/0269881107081553

Sharma, K. (2019). Cholinesterase inhibitors as Alzheimer’s therapeutics (Review). Molecular Medicine Reports, 20(2), 1479–1487. https://doi.org/10.3892/mmr.2019.10374

Shinohara, M., Sato, N., Shimamura, M., Kurinami, H., Hamasaki, T., Chatterjee, A., Rakugi, H., & Morishita, R. (2014). Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors. Frontiers in Aging Neuroscience, 6, 71. https://doi.org/10.3389/fnagi.2014.00071

Sirtori, C. R. (2014). The pharmacology of statins. Pharmacological Research, 88, 3–11. https://doi.org/10.1016/j.phrs.2014.03.002

Small, D. H. (2005). Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer’s disease: do we need new inhibitors? Expert Opinion on Emerging Drugs, 10(4), 817–825. https://doi.org/10.1517/14728214.10.4.817

Sparks, D. L., Sabbagh, M., Connor, D. J., Soares, H., Lopez, J., Stankovic, G., Johnson-Traver, S., Ziolkowski, C. H. J., & Browne, P. (2006). Statin therapy in Alzheimer’s disease. Acta Neurologica Scandinavica, 114(s185), 78–86. https://doi.org/10.1111/j.1600-0404.2006.00689.x

Vecchio, I., Sorrentino, L., Paoletti, A. M., Marra, R., & Arbitrio, M. (2021). The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer’s Disease. Journal of Central Nervous System Disease, 13, 117957352110291. https://doi.org/10.1177/11795735211029113

Vukšić, A., Lovrić, J., Konjevoda, P., Blažević, N., Bilušić, M., & Bradamante, V. (2019). Effects of simvastatin and fenofibrate on butyrylcholinesterase activity in the brain, plasma, and liver of normolipidemic and hyperlipidemic rats. Arhiv Za Higijenu Rada I Toksikologiju, 70(1), 30–35. https://doi.org/10.2478/aiht-2019-70-3215

Wilson, B. W., Arrieta, D. E., & Henderson, J. D. (2005). Monitoring cholinesterases to detect pesticide exposure. Chemico-Biological Interactions, 157–158, 253–256. https://doi.org/10.1016/j.cbi.2005.10.043

Zdrenghea, D., Bodizs, G., Predescu, D., Oprea, M., & Zdrenghea, M. (2002). The effect of simvastatin upon serum pseudocholinesterase and plasmatic factor VII. Romanian Journal of Internal Medicine, 40(1–4), 3–9. https://pubmed.ncbi.nlm.nih.gov/15526536

Zhang, X., Wen, J., & Zhang, Z. (2018). Statins use and risk of dementia: A dose-response meta-analysis. Medicine, 97(30), e11304. https://doi.org/10.1097/md.0000000000011304




How to Cite

Rashid, H. M. and Mohammad, F. K. (2023) “Differential effects of statins on plasma and brain cholinesterase activities in chicks”, Neuroscience Research Notes, 6(3), pp. 234.1–234.8. doi: 10.31117/neuroscirn.v6i3.234.